Octreotide prevents the early increase in renal insulin-like growth factor binding protein 1 in streptozotocin diabetic rats

Octreotide prevents the early increase in renal insulin-like growth factor binding protein 1 in streptozotocin diabetic rats. I Raz , D Rubinger , M Popovtzer , H Grønbaek , O Weiss and A Flyvbjerg Department of Internal Medicine, Hadassah University Hospital, Jerusalem, Israel. Abstract The early r...

Full description

Saved in:

Bibliographic Details
Published in:	Diabetes (New York, N.Y.) Vol. 47; no. 6; pp. 924 - 930
Main Authors:	RAZ, I, RUBINGER, D, POPOVTZER, M, GRØNBAEK, H, WEISS, O, FLYVBJERG, A
Format:	Journal Article
Language:	English
Published:	Alexandria, VA American Diabetes Association 01-06-1998
Subjects:	Animals Biological and medical sciences Blood Glucose - metabolism Body Weight - drug effects Diabetes Mellitus, Experimental - blood Diabetes Mellitus, Experimental - metabolism Diabetes Mellitus, Experimental - physiopathology Gene Expression Regulation - drug effects Gene Expression Regulation - physiology General and cellular metabolism. Vitamins Growth Hormone - blood Insulin - blood Insulin-like growth factor 1 Insulin-Like Growth Factor Binding Protein 1 - biosynthesis Insulin-like growth factor I Insulin-Like Growth Factor I - biosynthesis Kidney Kidney - drug effects Kidney - metabolism Kidneys Kinetics Male Medical sciences Octreotide - blood Octreotide - pharmacology Organ Size - drug effects Pharmacology. Drug treatments Physiological aspects Rats Rats, Inbred Strains Reference Values RNA, Messenger - biosynthesis Time Factors Transcription, Genetic - drug effects Endocrinopathy Kidney disease Urinary system disease Rat Diabetes mellitus Rodentia Octreotide Gene expression Kidney Insulin like growth factor binding protein Prevention Vertebrata Chemotherapy Experimental disease Mammalia Nephropathy Treatment Urinary system Animal Complication
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!